About

How It All Started

My journey began with a genuine, lifelong obsession with skincare. Long before founding CK Consulting, I was- and still am – a dedicated skincare enthusiast. I have spent years testing countlessly diverse formulas, textures, and active ingredients on my own skin, driven by curiosity and a pure passion for beauty innovation.

However, as a licensed pharmacist in both South Korea and the United States (PharmD), I couldn’t help but look at skincare through a scientific lens. For over a decade in global Pharmacovigilance (PV) and Consumer Safety, I oversaw post-market surveillance across highly complex therapeutic areas- including vaccines, oncology, and OTC consumer healthcare products.

As the U.S. cosmetic regulatory landscape evolved under MoCRA, I saw a crucial bridge waiting to be built.

Bridging Science, Safety, and Beauty

Korean skincare (K-Beauty) is globally celebrated for its innovation and formula elegance. Yet, navigating the stringent U.S. FDA compliance and adverse event reporting requirements can be a daunting hurdle for international brands.

I founded CK Consulting to bring big-pharma safety rigor to the cosmetics industry. By merging my dual-nation pharmacy background, a decade of high-stakes pharmacovigilance expertise, and a deep, personal understanding of skincare products, I offer a safety surveillance partner that truly understands both the science behind the bottle and the rules of the regulator.

Our Commitment

As your official U.S. Agent for cosmetic safety surveillance, we handle end-to-end adverse event management – from 24/7 bilingual intake and expert medical triage to mandatory 15-day FDA MedWatch reporting.

We exist to give Korean cosmetics manufacturers the safety foundation they need to launch, scale, and protect their brands in the U.S. market with total regulatory confidence.